Peak XV Partners’ (formerly Sequoia Capital India & SEA) Pieter Kemps is set to leave the company and its seed-stage accelerator, Surge, after over a decade at the firm, adding to a long list of senior-level departures. Kemps, who started in Singapore with Peak and has been in the Netherlands since the pandemic, is stepping…
India’s pursuit of better health is getting a pharmaceutical upgrade. Searches for GLP-1 drugs such as Ozempic, Zepbound, Tirzepatide, and Mounjaro surged triple digits in 2024, reflecting what research firm Kantar calls the “mainstream adoption” of medical-grade weight-loss solutions. Zepbound alone saw a staggering 943% spike, making it one of the fastest-rising health terms in…
Omnichannel retailer Bluestone’s initial public offering (IPO) was subscribed 39% on the first day of bidding on Monday, primarily led by strong traction from the qualified institutional buyers (QIB) category, with 57% of shares subscribed. This is an unusual trend, as QIB participation typically accelerates in the later stages of the offering as institutional investors…
From Bollywood actress Shipa Shetty joining lab-grown diamond startup Limelight to how Accel and Saama Capital are set to earn sizeable gains from Bluestone’s IPO, YourStory brings today’s headlines that highlight significant developments across the ecosystem. Featured stories: How Upsparks Capital carved out a niche in India’s pre-seed investments Bengaluru-based proprietary venture capital firm Upsparks Capital…
In the competitive world of AI, synthetic data—artificially generated datasets designed to mirror real-world statistical patterns—enables developers to overcome data scarcity, reduce manual labelling, and protect privacy by avoiding direct use of real individual records. Collected from statistical resampling and rule-based generation, learned models like GANs (Generative Adversarial Networks), and simulation pipelines, synthetic data can…
Limelight Lab Grown Diamonds on Monday onboarded actor and entrepreneur Shilpa Shetty as a strategic investor and the brand ambassador of the company. The Mumbai-based jeweller, which operates over 50 stores across more than 45 Indian cities, said the move is part of its strategy as it aims to expand to 100 outlets by 2026….
For decades, sending money across borders has been a slow, frustrating task—delayed settlements, limited transparency, and complex compliance checks. But that is changing fast. A new generation of fintech platforms is using artificial intelligence (AI) to transform this experience by deploying tools like real-time KYC, anomaly detection, and predictive fraud monitoring to make international transactions…
Accel India and Saama Capital are set to be the biggest beneficiaries from Bluestone’s initial public offering, with both early backers set to pocket hefty gains from sizeable stake sales. The omnichannel jewellery retailer is offering shares in the price band of Rs 492–Rs 517, promising multi-bagger returns for its venture investors. Among the biggest…
Epharmacy and telehealth platform Truemeds has raised $85 million in Series C funding to accelerate its push into smaller cities and towns. The financing, completed in two tranches, was led first by Accel and later by Peak XV Partners, with continued backing from WestBridge Capital and Info Edge Ventures. The Mumbai-based company said the capital…
Omnichannel jewellery player Bluestone has set its initial public offering’s pricing at Rs 492 to Rs 517 per share, according to the company’s exchange filings. On Friday, the Prosus-backed company raised over Rs 693 crore from anchor investors, three days before its IPO opening for subscription. Institutional investors that participated in the anchor book included…
